EMBC
Embecta Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.80
+1.93%Forward multiples
Based on analyst estimates
- P/E forward
- 3.61x
- P/E 2026E
- 3.17x
- P/E 2027E
- 3.30x
- P/E 2028E
- 2.99x
- P/S forward
- 0.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.89x
- PEG TTM
- 0.50x
- Price / book
- -0.54x
- Price / sales
- 0.32x
- Price / cash flow
- 1.89x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 1.59x
- EV / EBITDA
- 5.90x
- EV / EBIT
- 6.38x
- Market cap
- $328.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026